1-5 of 5
Authors: Timo Vaara
Journal Article
Polymyxin derivatives NAB739 and NAB815 are more effective than polymyxin B in murine Escherichia coli pyelonephritis
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 452–455, https://doi.org/10.1093/jac/dkx394
Published: 14 November 2017
Journal Article
Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 3, March 2013, Pages 636–639, https://doi.org/10.1093/jac/dks438
Published: 06 November 2012
Journal Article
Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 5, May 2010, Pages 981–985, https://doi.org/10.1093/jac/dkq072
Published: 16 March 2010
Journal Article
Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 5, May 2010, Pages 942–945, https://doi.org/10.1093/jac/dkq040
Published: 18 February 2010
Journal Article
Pharmacokinetics of novel antimicrobial cationic peptides NAB 7061 and NAB 739 in rats following intravenous administration Get access
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 5, November 2009, Pages 1067–1070, https://doi.org/10.1093/jac/dkp331
Published: 10 September 2009
